Junyuan Jerry Wang
About Junyuan Jerry Wang
Chief Executive Officer & Co-Founder of AnHeart Therapeutics
Junyuan Jerry Wang holds the title of Chief Executive Officer and is one of the co-founders of AnHeart Therapeutics. Established in 2018, AnHeart Therapeutics focuses on the development of innovative medicines. Under Wang’s leadership, the company has grown into a late-stage clinical organization. Wang has been at the forefront of the in-license and advancement of investigational medicines, including taletrectinib and safusidenib, facilitating their progress through the clinical trial phases.
Junyuan Jerry Wang's Extensive Industry Experience
Junyuan Jerry Wang brings over 20 years of experience in global clinical development and medical research to his role at AnHeart Therapeutics. His previous positions include tenures at pharmaceutical giants such as Merck Serono, Bristol Myers Squibb, Wyeth/Pfizer, The Medicines Company, and Merck & Co. This extensive background has provided him with a wealth of knowledge and expertise in the pharmaceutical industry.
Junyuan Jerry Wang's Contributions to Approved NDAs
During his extensive career in the pharmaceutical industry, Junyuan Jerry Wang has made significant contributions to the successful New Drug Applications (NDAs) of Bosulif and Eliquis. His work in these projects showcases his capability in driving drug development processes to achieve regulatory approval and market entry.
Global Health Authorities Expertise
Junyuan Jerry Wang has extensive experience interacting with global health authorities, including the U.S. FDA, EMA, Japan’s PMDA, and China’s NMPA. His work with these regulatory bodies ensures that investigational medicines meet necessary regulatory requirements, facilitating their progress from clinical trials to patient availability.
Education and Professional Involvement of Junyuan Jerry Wang
Junyuan Jerry Wang earned his B.S. from the University of Science and Technology of China and a Ph.D. in Statistics from Iowa State University. Beyond his formal education, Wang has been actively involved in professional societies, serving in leadership roles such as the Executive Committee of the Biopharmaceutical section of the American Statistical Association. He has also contributed to the programming committee of leading scientific conferences.